# Aytu Biopharma, Inc: Form 8-K, filed May 14, 2025

- Company: [Aytu Biopharma, Inc](/companies/aytu.md) (CIK 1385818)
- Form: 8-K
- Filed: 2025-05-14
- Accepted by EDGAR: May 14, 2025, 16:06 ET
- Period: 2025-05-14
- Accession: 0001437749-25-016832
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1385818/000143774925016832/aytu20250213_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1385818/000143774925016832/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1385818/000143774925016832/aytu20250213_8k.htm

Filed May 14, 2025.
Source: SEC EDGAR, the filing index for accession 0001437749-25-016832. Last ingested by Listed: Oct 27, 2026, 16:32 ET. No prices; not investment advice.